UPSC Civil Services · 2015 · GS 4

Ethical dilemmas and stakeholder reasoning

“Case-Study: To do Drug Research on non-profitable disease or not? One of the scientists working in the R & D laboratory of a major pharmaceutical company discovers that one of the company’s best selling veterinary drugs, B has the potential to cure a currently incurable liver disease that is prevalent in tribal areas. However, developing a variant of the drug suitable for human beings entailed a lot of research and development having a huge expenditure to the extent of 50 crores rupees. It was unlikely that the company would recover the costs as the disease was rampant only in poverty-stricken area having very little market otherwise. If you were the CEO, then— (a) Identify the various actions that you could take; (b) Evaluate the pros and cons of each of your actions.”

Original exam: 20 marks

Official UPSC paper archive ↗

This question is available to read here. The practice button generates a fresh question from the same paper. Here, practise an answer plan in keywords. Choose your timer on the next screen. Feedback uses our common 15-point practice rubric, rather than the paper’s original mark allocation.

Brainstorm this paper →

This theme in the news

GS 3 · Economy & agriculture

U.S. Tariff Waiver on Speciality Drugs and Implications for India’s Pharmaceutical Export Sector

On September 29, 2026, the United States announced a zero-percent tariff regime for specific categories of speciality drugs imported from 20 nations, including India. This policy adjustment targets life-saving pharmaceutical segments, including gene therapies, cell therapies, antibody-drug conjugates, rare disease medications, and infertility treatments. By removing tariff barriers for these complex medical products, the U.S. aims to diversify its pharmaceutical supply chains and lower costs for advanced healthcare. For India, the 'pharmacy of the world', this decision creates a significant incentive to transition beyond traditional generic manufacturing toward high-value biopharmaceuticals and complex medicinal components.

GS 3 · Science, technology & security

ED Attachment of ₹442 Crore in RummyCulture Case: Investigating Financial Irregularities in Online Gaming

On September 28, 2026, the Enforcement Directorate (ED) provisionally attached assets worth ₹442 crore linked to the online gaming platform RummyCulture under the Prevention of Money Laundering Act (PMLA). The probe, rooted in multiple FIRs filed in Telangana, reflects escalating scrutiny into the Indian online real-money gaming sector. Regulatory agencies are increasingly investigating how such platforms, often operating with complex digital payment architectures, are used to facilitate money laundering, tax evasion, and the illegal transfer of funds. This event underscores the challenges of governing a rapidly expanding digital market that sits at the intersection of entertainment, technology, and economic security.

GS 4 · Ethics & integrity

President Murmu Urges Film Personalities Against Endorsing Harmful Health Products at National Film Awards

At the seventy-second National Film Awards ceremony held at Ekta Nagar near the Statue of Unity, President Droupadi Murmu commended the Indian cinema industry for its expansive cultural reach while issuing a sharp caution against endorsing harmful health products. Emphasizing that a true star spreads light rather than darkness, the President highlighted the profound moral and social responsibilities borne by public figures whose commercial choices directly shape public health, impressionable youth, and societal values.